Test to Treat for Paxlovid

Pharmacists are permitted to order and prescribe the oral antiviral, Paxlovid, under certain conditions, for eligible patients who test positive for COVID-19. FDA recently recognized pharmacists’ expertise by revising Paxlovid’s EUA to include pharmacists among other health care professionals permitted to prescribe this therapeutic medication.

More information about implementing testing and treatment services is provided below.

APhA Member Only Resource

Log in or join to unlock this resource.

Many paths. One home.

APhA is the home of pharmacy. Never stop learning, never stop connecting. This is where pharmacy unites.

Learn more

APhA Members:

Login

OR

Guests:

Join APhA

If you need assistance, APhA membership is available to answer any questions at (800) 237-APhA (2742), Monday–Friday, between 8:30 am and 5:00 pm Eastern. For email inquiries, contact us (Note: do not email enrollment forms for security reasons).

Tags:

practice Immunization Center Coronavirus Test-to-Treat